Terumo Medical Corporation (TMC) develops, manufactures, and markets a complete, solutions-based portfolio of high-quality medical devices used in a broad range of applications for numerous areas of the healthcare industry. TMC places a premium on providing customers with world-class products, training and education programs that drive clear economic value, better clinical outcomes and improved quality of life for patients. TMC is part of Tokyo-based Terumo Corporation; one of the world’s leading medical device manufacturers with almost $5 billion in sales and operations in more than 160 nations. Terumo Medical Corporation is comprised of two strategic business divisions: Terumo Interventional Systems and Terumo Medical Products
Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally-invasive entry site management, lesion access and embolization solutions. TIS is committed to pursuing unique technologies designed to enhance treatment of endovascular and urological diseases, and driving strategic initiatives focused on Critical Limb Ischemia, Complex Coronary Intervention and Transradial Access.
Terumo Medical Products (TMP), a division of Terumo Medical Corporation, is recognized for its wide range of industry leading products that enhance patient comfort as well as the safety of front-line clinicians who provide high-quality care in outpatient and acute care settings. TMP’s core business also offers products designed for veterinary needs. In addition to its clinical business, TMP focuses on meeting the growing needs of customers in the specialty pharmaceutical market.
Founded: 1972, Headquarters: Somerset, New Jersey, Manufacturing/Product Development Sites: Elkton, Maryland and Irvine, California
